Efficacy of Therapeutic Exercise in Reversing Decreased Strength, Impaired Respiratory Function, Decreased Physical Fitness, and Decreased Quality of Life Caused by the Post-COVID-19 SyndromeReview Published on 2022-12-152023-07-11 Journal: Viruses [Category] COVID19(2023년), [키워드] exercise fatigue Long COVID-19 physical fitness post-COVID-19 Quality of life Respiratory function SARS-CoV-2 [DOI] 10.3390/v14122797 PMC 바로가기 [Article Type] Review
Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial재조합 인터페론 무장 융합 단백질 백신(V-01)을 사용한 SARS-CoV-2에 대한 이종 부스팅의 효능: 무작위, 이중 맹검 및 위약 대조 3상 시험Clinical Trial Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 임상, 진단, [키워드] adverse event antibody assigned booster clinical trial common adverse event conducted COVID-19 vaccine COVID-19 vaccines dose double-blind dramatic increase Efficacy elicit eligible fatigue Fever fusion protein groups headache healthy Heterologous heterologous boosting Humoral immunity Identifier Immunity inactivated Inactivated vaccine Inactivated Vaccines Inc injection injection site intention-to-treat principle Malaysia Mild-to-moderate Neutralizing Neutralizing antibodies occurred Older omicron Omicron variant over Pain participant Participants Placebo placebo-controlled primary endpoint Randomized Randomly receive regimen robust Safe SARS-CoV-2 SARS-COV-2 infection second dose Serious Adverse Events subunit Subunit vaccine Surveillance symptomatic SARS-CoV-2 infection the epidemic titre Trial Trial registration V-01 Vaccine vaccine efficacy variant virus-neutralizing antibodies was measured were assessed [DOI] 10.1080/22221751.2022.2088406 PMC 바로가기 [Article Type] Clinical Trial
Omicron infections profile and vaccination status among 1881 liver transplant recipients: a multi-centre retrospective cohortArticle Published on 2022-12-012022-11-16 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome adverse event adverse events Breakthrough infection China clinical manifestation Cohort collected concerning conducted coronavirus Coronavirus disease 2019 COVID-19 COVID-19 vaccination decrease Efficacy enrolled fatigue feature grade 3 higher risk inactivated Inactivated vaccine Infection infections liver liver dysfunction Liver transplantation Mild myalgia occurred omicron participant Patient patients postoperative protection rate. recipient retrospective cohort Retrospective study Safe safety profile SARS-CoV-2 Seven vaccination Vaccine variant viral shedding were infected whole-virion SARS-CoV-2 vaccine [DOI] 10.1080/22221751.2022.2136535 PMC 바로가기
Variation in SARS-CoV-2 seroprevalence in children in the region of Asturias, Northern SpainArticle Published on 2022-12-012022-11-15 Journal: World Journal of Pediatrics [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI 95% confidence interval acute respiratory syndrome analyzed antibodies Asturias change Child children close contact collected Contact tracing coronavirus coronavirus disease COVID-19 epidemiological estimate Evolution of SARS-CoV-2 Factor fatigue Features longitudinal change median age multicenter multivariable analysis occurred positive Prospective public health recruited SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody test SARS-CoV-2 seroprevalence Seroepidemiologic studies seronegative seropositive Spain subject Symptom Symptoms variable venous blood Virological virological test [DOI] 10.1007/s12519-022-00617-2 PMC 바로가기
What are the long-term holistic health consequences of COVID-19 among survivors? An umbrella systematic reviewArticle Published on 2022-12-012022-11-16 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, [키워드] acute COVID-19 acute phase acute respiratory syndrome affected conducted consequence coronavirus COVID-19 COVID-19 treatments demographic data determine eligibility criteria employment Epidemiology fatigue functional Health Impact individual Laboratory parameters memory Pandemics Participants physical Psychological psychological impacts Quality of life ranged Research respiratory symptoms Sample SARS Coronavirus screened survived Survivors systematic review systematic reviews variant virus virus classification [DOI] 10.1002/jmv.28086 PMC 바로가기
Women’s Experiences of Symptoms of Suspected or Confirmed COVID-19 Illness During the PandemicArticle Published on 2022-12-012023-07-10 Journal: Nursing for Women's Health [Category] COVID19(2023년), [키워드] Anxiety COVID-19 CovidWatcher fatigue mental health Novel coronavirus pandemic SARS-CoV-2 Symptoms women’s health [DOI] 10.1016/j.nwh.2022.09.005 PMC 바로가기
Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trialArticle Published on 2022-11-022022-11-15 Journal: BMJ Open [Category] SARS, 진단, [키워드] approved assessment baseline Blood Cardiology case sery chronic fatigue syndrome chronic inflammation clinical clinical trial cognitive collected common COVID-19 defined domain double-blind dysfunction Effect effective Efficacy endothelial function Ethics evaluate fatigue healthy subject hyperbaric oxygen hypothese immunology IMPROVE Inconclusive independent individual initial institutional review board Long malaise mechanism monitoring board oxygen Oxygen therapy pandemic Patient peer-reviewed performed physical placebo-controlled placebo-controlled clinical trial positive Potential treatment product protocol Quality of life Questionnaires randomised rehabilitation medicine respiratory medicine (see thoracic medicine) secondary endpoint suggested survey Swedish Symptom syndrome the primary endpoint Treatment Trial VASCULAR MEDICINE. [DOI] 10.1136/bmjopen-2022-061870 PMC 바로가기
Genetics of COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome: a systematic reviewArticle Published on 2022-11-012022-11-16 Journal: Annals of Clinical and Translational Neurology [Category] 변종, [키워드] ACE affected Analysis association chemokine cohort study components conditions COVID-19 cytokine signaling Enzymes evolutionary relationship expression fatigue functional annotation Genetic genetic component Genetic variant highlight HLA-A HLA-C HLA-DQA1 HLA-DRB1 immune dysfunction Inflammation investigated Mental Ontology Pathogenesis Pathway analysis Pathways performed physical Protein Proteins receptor signaling significantly similarity Symptoms syndrome systematic review T cell activation TYK2 [DOI] 10.1002/acn3.51631 PMC 바로가기
Prevalence, trajectory over time, and risk factor of post-COVID-19 fatigueArticle Published on 2022-11-012022-11-15 Journal: Journal of psychiatric research [Category] 치료제, [키워드] bootstrap Characteristics Clarifying collected Course COVID-19 COVID-19 severity Depression depressive evaluated fatigue identify independent Intervention mechanism overlapping Patient physical post-COVID fatigue post-COVID syndrome predict predicted predictor Prevalence question rehabilitation remained reported symptom risk factor SARS-CoV-2 scale severity specific treatment Symptom Symptoms syndrome trajectory worsening [DOI] 10.1016/j.jpsychires.2022.08.008 PMC 바로가기
Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS-CoV-2 spike protein vaccine as a homologous and heterologous booster vaccination: A randomized placebo-controlled trialArticle Published on 2022-11-012022-11-15 Journal: Immunology [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] 95% confidence interval Administered adverse event approved assessment booster booster dose booster vaccination clinical trials Course COVID-19 COVID-19 vaccination COVID-19 vaccine cross-neutralization cross-neutralization. Day double-blind Effect fatigue Heterologous homologous humoral immunogenic immunogenicity incidence injection site pain Local Neutralizing antibodies neutralizing antibody outcome participant Participants Placebo placebo-controlled primary immunogenicity Randomized randomized placebo-controlled trial Recombinant spike protein reported robust Safe Safety safety profile saline placebo SARS-CoV-2 SARS-CoV-2 spike protein SARS-CoV-2 variants Serious Adverse Event Serious Adverse Events Seroconversion seroconversion rate shown SpikoGen subunit the placebo group Trial Vaccine was performed [DOI] 10.1111/imm.13540 PMC 바로가기